Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHCR7 | Q9UBM7 | 3/20 | 0.79 |
| ▸ | ABCB1 | P08183 | 13/20 | 0.70 |
| ▸ | ABCG2 | Q9UNQ0 | 7/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | CA2 | P00918 | 1/20 | 0.58 |
| ▸ | CA9 | Q16790 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17664977 | 1.00 | DHCR7 (0.79) | DHCR7ABCB1ABCG2KDM4ETDP1 | |
| SCHEMBL2771882 | 0.92 | ABCB1 (0.78) | DHCR7ABCB1ABCG2 | |
| Hydrochloric Acid SCHEMBL10661663 | 0.90 | ABCB1 (0.76) | DHCR7ABCB1ABCG2 | |
| SCHEMBL3042454 | 0.89 | DHCR7 (0.81) | DHCR7ABCB1ABCG2KDM4ETDP1 | |
| SCHEMBL14740411 | 0.88 | DHCR7 (0.79) | DHCR7ABCB1ABCG2KDM4ETDP1 | |
| SCHEMBL14739580 | 0.88 | DHCR7 (1.00) | DHCR7ABCB1ABCG2KDM4ETDP1 | |
| SCHEMBL3504140 | 0.88 | DHCR7 (0.79) | DHCR7ABCB1ABCG2KDM4ETDP1 | |
| SCHEMBL14740106 | 0.87 | DHCR7 (1.00) | DHCR7ABCB1ABCG2KDM4ETDP1 | |
| Verilopam SCHEMBL489188 | 0.85 | ABCB1 (0.68) | DHCR7ABCB1ABCG2 | |
| SCHEMBL8790535 | 0.84 | ABCB1 (0.68) | DHCR7ABCB1ABCG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3200779-B1 | NOVEL ANTHRANILIC ACID DERIVATIVES | MAHESHWARI DIVYA (IN) | 2022-03-23 | — | — | EP | disclosed |
| US-10561748-B2 | Anthranilic acid derivatives | MAHESHWARI DIVYA (IN) | 2020-02-18 | — | — | US | disclosed |
| US-20170281805-A1 | NOVEL ANTHRANILIC ACID DERIVATIVES | MAHESHWARI DIVYA (IN) | 2017-10-05 | — | — | US | disclosed |
| EP-3200779-A2 | NOVEL ANTHRANILIC ACID DERIVATIVES | Maheshwari, Divya (IN) | 2017-08-09 | — | — | EP | disclosed |
| WO-2016051306-A2 | NOVEL ANTHRANILIC ACID DERIVATIVES | MAHESHWARI DIVYA (IN) | 2016-04-07 | — | — | WO | disclosed |
| US-20120330020-A1 | METHOD FOR PREPARING TETRAZOLE METHANESULFONIC ACID SALTS, AND NOVEL COMPOUND USED IN SAME | HANMI SCIENCE CO., LTD (KR) | 2012-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170281805-A1 | NOVEL ANTHRANILIC ACID DERIVATIVES | SLC47A1, ABCC1, ABCB1 | DHCR7 1395/4885ABCB1 3/4885ABCG2 12/4885 |
| US-10561748-B2 | Anthranilic acid derivatives | SLC47A1, ABCC1, ABCB1 | DHCR7 1590/4885ABCB1 3/4885ABCG2 14/4885 |
| US-20120330020-A1 | METHOD FOR PREPARING TETRAZOLE METHANESULFONIC ACID SALTS, AND NOVEL COMPOUND USED IN SAME | TST, MPST, STS | DHCR7 221/4885ABCB1 3899/4885ABCG2 1697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.